Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Grem

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Molecular Pharmacology|March 14, 1998
Modulation of fluorouracil cytotoxicity by interferon-alpha and -gammaA Ismail, C J Van Groeningen, A Hardcastle, et al.
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
AntimetabolitesJ L Grem, C H Takimoto, P Multani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusionsH Bailey, G Wilding, K D Tutsch, et al.
Journal of Chromatography. B, Biomedical Applications|April 22, 1994
Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatographyC H Takimoto, R W Klecker, W L Dahut, et al.
Oncology Research|January 1, 1997
Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cellsQ Ren, C J Van Groeningen, A Hardcastle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretionD L Trump, J L Grem, K D Tutsch, et al.
Molecular Pharmacology|August 1, 1995
Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cellsJ L Grem, F Geoffroy, P M Politi, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
AntimetabolitesP G Johnston, C H Takimoto, J L Grem, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of taxol administered as a short i.v. infusion daily for 5 daysJ L Grem, K D Tutsch, K J Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, R F Murphy, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Molecular Pharmacology|March 14, 1998
Modulation of fluorouracil cytotoxicity by interferon-alpha and -gammaA Ismail, C J Van Groeningen, A Hardcastle, et al.
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
AntimetabolitesJ L Grem, C H Takimoto, P Multani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusionsH Bailey, G Wilding, K D Tutsch, et al.
Journal of Chromatography. B, Biomedical Applications|April 22, 1994
Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatographyC H Takimoto, R W Klecker, W L Dahut, et al.
Oncology Research|January 1, 1997
Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cellsQ Ren, C J Van Groeningen, A Hardcastle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretionD L Trump, J L Grem, K D Tutsch, et al.
Molecular Pharmacology|August 1, 1995
Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cellsJ L Grem, F Geoffroy, P M Politi, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
AntimetabolitesP G Johnston, C H Takimoto, J L Grem, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of taxol administered as a short i.v. infusion daily for 5 daysJ L Grem, K D Tutsch, K J Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinomaJ L Grem, N McAtee, R F Murphy, et al.
Pageof 12